Literature DB >> 1708234

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

P K Anonick1, S L Gonias.   

Abstract

The kinetics of plasmin inhibition by alpha 2-antiplasmin (alpha 2AP), alpha 2-macroglobulin (alpha 2M) and leupeptin were studied in the presence of fibrin monomer (Fn) and CNBr fragments of fibrinogen (Fg-CNBr). Active plasmin was detected in continuous and discontinuous assays using the chromogenic substrate D-Val-L-Leu-L-Lys p-nitroanilide hydrochloride (S-2251). The two 'fibrin-like' preparations functioned as hyperbolic mixed-type inhibitors of S-2251 hydrolysis. The dissociation constants (KF) for the binding of plasmin to Fn and Fg-CNBr were 22 nM and 17 nM respectively. Fn and Fg-CNBr inhibited the reaction of plasmin with alpha 2AP: the extent of inhibition depended on the fibrin concentration. In the presence of 800 nM-Fn or 800 nM-Fg-CNBr, the experimental second-order rate constant (K"app.) was decreased from 2.4 x 10(7) M-1.s-1 to 1.2 x 10(6) and 5.3 x 10(5) M-1.s-1 respectively. The effect of Fn and Fg-CNBr on the rate of plasmin inhibition by alpha 2M was even greater. The k"app. value was decreased from 4.0 x 10(5) M-1.s-1 to 8.0 x 10(2) and 1.3 x 10(3) M-1.s-1 in the presence of 800 nM-Fn and -Fg-CNBr respectively. By contrast, the fibrin preparations caused only a small change in the rate of plasmin inhibition by leupeptin. The maximum change in k"app. was 3-fold. All plasmin inhibition curves were linear, suggesting that free and fibrin-bound forms of plasmin remained in equilibrium during the course of reaction with proteinase inhibitors. Fn and Fg-CNBr had no effect on the reaction of miniplasmin with S-2251, alpha 2AP or alpha 2M. When 125I-plasmin was incubated with Fg-CNBr and then allowed to react with a premixed solution of alpha 2AP and alpha 2M, the Fg-CNBr did not significantly change the percentage of plasmin bound to alpha 2AP. These experiments demonstrate that the reaction of plasmin with alpha 2M is inhibited by the non-covalent binding of plasmin to fibrin. We propose that plasmin bound to the surface of a clot is protected from inhibition by alpha 2M as well as by alpha 2AP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708234      PMCID: PMC1150012          DOI: 10.1042/bj2750053

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Kinetic studies on the effect of heparin and fibrin on plasminogen activators.

Authors:  R Fears
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

3.  Limited proteolysis of tumor cells increases their plasmin-binding ability.

Authors:  M Camacho; M C Fondaneche; P Burtin
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

4.  Kinetics of the inhibition of free and elastin-bound human pancreatic elastase by alpha 1-proteinase inhibitor and alpha 2-macroglobulin.

Authors:  P Laurent; J G Bieth
Journal:  Biochim Biophys Acta       Date:  1989-02-23

Review 5.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

6.  Biological activities of leupeptins.

Authors:  T Aoyagi; S Miyata; M Nanbo; F Kojima; M Matsuzaki
Journal:  J Antibiot (Tokyo)       Date:  1969-11       Impact factor: 2.649

7.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

Authors:  R Pannell; J Black; V Gurewich
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

8.  The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

Authors:  R Cassels; R Fears; R A Smith
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

9.  Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells.

Authors:  L A Miles; C M Dahlberg; E G Levin; E F Plow
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

10.  Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.

Authors:  P K Anonick; B Wolf; S L Gonias
Journal:  Thromb Res       Date:  1990-08-01       Impact factor: 3.944

View more
  13 in total

1.  Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.

Authors:  S Christensen; L Sottrup-Jensen; U Christensen
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

2.  Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.

Authors:  Satish Singh; Timsy Bhando; Kanak L Dikshit
Journal:  Protein Sci       Date:  2014-04-05       Impact factor: 6.725

3.  alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds.

Authors:  B M Schaefer; K Maier; U Eickhoff; M Bechtel; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

4.  Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein.

Authors:  Vishwanatha Chandrahas; Kristofor Glinton; Zhong Liang; Deborah L Donahue; Victoria A Ploplis; Francis J Castellino
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

5.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

7.  Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.

Authors:  D J Webb; A M Weaver; T L Atkins-Brady; S L Gonias
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

8.  Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.

Authors:  J M Edelberg; S V Pizzo
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

9.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells.

Authors:  J S Turner; G T Redpath; J E Humphries; S L Gonias; S R Vandenberg
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.